NASDAQ:IPOA Teladoc Health (IPOA) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free IPOA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.66▼$11.8150-Day Range$11.79▼$11.7952-Week Range N/AVolume6.45 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Teladoc Health alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Teladoc Health Stock (NASDAQ:IPOA)Social Capital Hedosophia Holdings Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2017 and is based in Palo Alto, California.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> IPOA Stock News HeadlinesApril 5, 2024 | marketbeat.comLong-time Teladoc leader departs as virtual care provider struggles with post-COVID tumbleThe leader of struggling telemedicine provider Teladoc Health has left effective immediately, the company announced FridayApril 25, 2024 | gurufocus.comTeladoc Health Inc. (TDOC) Q1 2024 Earnings: Misses on EPS, Surpasses Revenue ExpectationsApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 24, 2024 | msn.comTeladoc Health Q1 Preview: Mental health segment could help earningsApril 17, 2024 | markets.businessinsider.comTDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost MoneyApril 6, 2024 | msn.comTeladoc Stock (NYSE:TDOC): No Need to Risk Your Financial HealthApril 5, 2024 | msn.comTeladoc Health (NYSE:TDOC) CEO Abruptly Departs; CFO Takes Helm Amid TransitionApril 5, 2024 | msn.comTeladoc's CEO departs suddenly as visits are down and the stock sinksApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 5, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alnylam Pharma (ALNY)April 5, 2024 | markets.businessinsider.comWhat 9 Analyst Ratings Have To Say About Teladoc HealthApril 5, 2024 | marketwatch.comTeladoc Health Names Mala Murthy Acting CEO as Jason Gorevic DepartsMarch 18, 2024 | benzinga.comHow Is The Market Feeling About Teladoc Health?February 26, 2024 | forbes.comLeading A Healthcare Revolution: Teladoc CEO’s Telemedicine JourneyFebruary 26, 2024 | markets.businessinsider.comWhere Teladoc Health Stands With AnalystsFebruary 21, 2024 | msn.comTeladoc stock is plunging because virtual doctor's visits aren't what they used to beFebruary 21, 2024 | msn.comTeladoc sends health tech stocks lower after Q4 resultsFebruary 21, 2024 | msn.comTeladoc Health Stock Is Plunging. What the CEO Said After Earnings Missed.February 21, 2024 | benzinga.comTeladoc Health Delivers Mixed Results, 'Sobering' Guidance: 6 Analysts Provide Key TakeawaysFebruary 21, 2024 | msn.comWhy Is Teladoc Health (TDOC) Stock Down 21% Today?February 20, 2024 | marketwatch.comTeladoc’s stock dives after it forecasts slower growth in virtual healthcareFebruary 20, 2024 | marketwatch.comTeladoc Health Shares Slide 14% on 1Q, 2024 OutlookFebruary 20, 2024 | msn.comTeladoc’s stock sinks on downbeat forecastFebruary 1, 2024 | markets.businessinsider.comTeladoc Health to Announce Fourth Quarter 2023 Financial ResultsFebruary 1, 2024 | investorplace.com3 Once-in-a-Lifetime Healthcare Technology Stocks With Unprecedented Surge PotentialJanuary 23, 2024 | msn.com2 Reasons to Buy Teladoc Health Stock, and 1 Reason to Avoid It Like the PlagueJanuary 21, 2024 | seekingalpha.comTeladoc Health: Weight Management RescueSee More Headlines Receive IPOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Conglomerates Sub-IndustryN/A Current SymbolNASDAQ:IPOA CUSIPN/A CIKN/A Webwww.socialcapitalhedosophiaholdings.com Phone650-521-9007FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Chamath Palihapitiya (Age 42)CEO & Chairman Mr. Ian Osborne (Age 36)Pres & Director Mr. Steven Trieu (Age 40)Chief Financial Officer Mr. Simon Williams (Age 39)Gen. Counsel & Sec. Key CompetitorsCresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y AgropecuariaNASDAQ:CRESWFalcon's Beyond GlobalNASDAQ:FBYDWFalcon's Beyond GlobalNASDAQ:FBYDPADS-TEC EnergyNASDAQ:ADSEWAeries TechnologyNASDAQ:AERTWView All Competitors IPOA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Teladoc Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Okta (OKTA), PayPal (PYPL), Adobe (ADBE), Salesforce (CRM), Pfizer (PFE), Shopify (SHOP), Trade Desk (TTD), Twilio (TWLO) and Visa (V). This page (NASDAQ:IPOA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teladoc Health Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
